Cost-effectiveness of universal BRCA1/2 screening: Evidence-based decision making

JAMA Oncology

Volumn 1, Issue 9, 2015, Pages 1217-1218

  Long, Elisa F ^a   Ganz, Patricia A ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST NEOPLASMS; COST BENEFIT ANALYSIS; DECISION MAKING; EARLY CANCER DIAGNOSIS; ECONOMICS; EVIDENCE BASED MEDICINE; FEMALE; GENETICS; HUMAN; MAMMOGRAPHY; MUTATION; QUALITY ADJUSTED LIFE YEAR; TUMOR SUPPRESSOR GENE; UNITED STATES;

BREAST NEOPLASMS; COST-BENEFIT ANALYSIS; DECISION MAKING; EARLY DETECTION OF CANCER; EVIDENCE-BASED MEDICINE; FEMALE; GENES, BRCA1; GENES, BRCA2; HUMANS; MAMMOGRAPHY; MUTATION; QUALITY-ADJUSTED LIFE YEARS; UNITED STATES;

EID: 84951907411     PISSN: 23742437     EISSN: 23742445     Source Type: Journal    
DOI: 10.1001/jamaoncol.2015.2340     Document Type: Short Survey

References (7)

1. US Breast Cancer Statistics. 2014; http://www.breastcancer.org/symptoms/understand-bc/statistics. Accessed July 13, 2015.
2. King MC, Levy-Lahad E, Lahad A. Population-based screening for BRCA1 and BRCA2: 2014 Lasker Award. JAMA. 2014;312(11):1091-1092.
3. Manchanda R, Legood R, Burnell M, et al. Cost-effectiveness of population screening for BRCA mutations in Ashkenazi Jewish women compared with family history-based testing. J Natl Cancer Inst. 2015;107(1):380.
4. Grann VR, Patel PR, Jacobson JS, et al. Comparative effectiveness of screening and prevention strategies among BRCA1/2-affected mutation carriers. Breast Cancer Res Treat. 2011;125(3):837-847.
5. Plevritis SK, Kurian AW, Sigal BM, et al. Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging. JAMA. 2006;295(20):2374-2384.
6. Schousboe JT, Kerlikowske K, Loh A, Cummings SR. Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness. Ann Intern Med. 2011;155(1):10-20.
7. Moore SG, Shenoy PJ, Fanucchi L, Tumeh JW, Flowers CR. Cost-effectiveness of MRI compared to mammography for breast cancer screening in a high risk population. BMC Health Serv Res. 2009;9:9.